Virpax inks ‘patch-in-a-can’ deal for pain management

By Flora Southey contact

- Last updated on GMT

MedPharm's MedSpray 'patch-in-a-can' technology
MedPharm's MedSpray 'patch-in-a-can' technology
Virpax Pharmaceuticals has licensed MedPharm’s topical spray technology to develop a transdermal patch for non-opioid pain management products.

Under the agreement, US-based Virpax will develop an investigational spray film designed to deliver nonsteroidal anti-inflammatory drug (NSAID) DSF100 using MedPharm’s metered-dose spray, MedSpray. Financial terms were not disclosed.

The metered-dose aerosol spray – which MedPharm describes as a ‘patch-in-a-can’ – forms a thin film on the skin or mucosal membrane, enabling the transdermal delivery of NSAIDs.  

According to UK-headquartered MedPharm, the technology “features a high level of adhesiveness, accessibility and skin drying.”

In addition, “compared to a standard topical spray MedSpray gives extended release and compared to a standard patch MedSpray is invisible,” ​the spokesperson told us.

The US Food and Drug Administration granted a pre-investigational new drug meeting request for DSF100 in May this year.

Virpax is exploring other transdermal drug delivery technologies for pain management. Last month​, the US firm signed a license agreement for LipoCure’s long-active liposomal gel, to develop anaesthetics for post-operative pain.

“We believe there is an opportunity to explore the development of non-opioid transdermal pain treatments that improve on existing gel and patch products, for which adhesion and accessibility can be a challenge,”​ said Virpax CEO Anthony Mack in a statement​.

Related topics: Drug Delivery, Delivery technologies

Related news

Show more

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Flow Cytometry Services

Flow Cytometry Services

Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...